A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

NCT06104124 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

651

Enrollment

INDUSTRY

Sponsor class

Conditions

Sjogren's Syndrome

Interventions

DRUG: Dazodalibep
DRUG: Placebo

Sponsor

Amgen